Ecolab have announced that its Purolite resin business, together with Repligen Corporation has commercially launched Purolite’s DurA Cycle, a protein A chromatography resin for large-scale purification processes.
Sanofi, Formation Bio and OpenAI are collaborating to build AI-powered software to accelerate drug development and bring new medicines to patients more efficiently.
Biocon Biologics Limited have announced a long -term commercial collaboration with Eris Lifesciences to expand patient access to its portfolio of Metabolics, Oncology, and Critical Care products in India.
Takeda and Biological E. Limited, an India-based vaccines and pharmaceutical company, have announced a strategic partnership to accelerate access to QDENGA (Dengue Tetravalent Vaccine [Live, Attenuated]) (TAK-003) multi-dose vials.
Cognizant have announced an expanded agreement with Takeda a global biopharmaceutical company, to support the company’s digital transformation strategy by reinforcing and supporting its technology efforts.
Futura Medical plc has extended until January 2029 its exclusive licensing agreement with Cooper Consumer Health to commercialise Eroxon, the Company's topical, gel-based Erectile Dysfunction treatment.
Isomorphic Labs have announced that it has entered into a strategic research collaboration with Eli Lilly and Company and a strategic research collaboration with Novartis to discover small molecule therapeutics against three undisclosed targets.
Shionogi B.V., the European subsidiary of SHIONOGI & Co., Ltd. have announced that they have signed a distribution agreement with Swedish Orphan Biovitrum AB, Sobi, for Fetcroja covering 13 countries in Central & Eastern Europe.
Organon have announced an agreement with Eli Lilly and Company to become the sole distributor and promoter for the migraine medicines Emgality (galcanezumab) and RAYVOW (lasmiditan) in Europe.
Ypsomed has concluded a long-term supply agreement with Novo Nordisk for large quantities of autoinjectors. The autoinjectors will be used to administer drugs for the self-treatment in various metabolic indications.
